IPA (IMMUNOPRECISE ANTIBODIES LTD.) announced that it has accepted the resignation of Brad McConn, CFO, effective September 29, 2023. IPA has named Kristin Taylor, MBA, CPA, as interim Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | +2.02% | 0.00% | -40.94% |
06-27 | ImmunoPrecise Antibodies Ltd. Appoints Kristin Taylor as Permanent Chief Financial Officer | CI |
06-25 | ImmunoPrecise Antibodies Unit, PGxAI to Develop AI Model to Predict Treatment Responses | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.94% | 26.58M | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- IPA Stock
- News ImmunoPrecise Antibodies Ltd.
- ImmunoPrecise Antibodies Announces CFO Transition